Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person The complex of phosphorylated SMAD2/3 and SMAD4, bound to FO...

Class:IdSummation:9618007
_displayNameThe complex of phosphorylated SMAD2/3 and SMAD4, bound to FO...
_timestamp2018-09-01 12:08:45
created[InstanceEdit:9618008] Orlic-Milacic, Marija, 2018-08-31
modified[InstanceEdit:9618027] Orlic-Milacic, Marija, 2018-09-01
textThe complex of phosphorylated SMAD2/3 and SMAD4, bound to FOXO3, binds to the promoter of the CDKN1A gene. The p-2S-SMAD2/3:SMAD4 complex bound to FOXO1 or FOXO4 can probably also bind to the CDKN1A gene promoter. FOXG1 binding to the FOXO:SMAD complex inhibits FOXO:SMAD-mediated upregulation of CDKN1A transcription. FOXG1 plays an important role in sustained proliferation of telencephalic neuroepithelial progenitor cells (Seoane et al. 2004).
(summation)[Reaction:9618004] FOXO:SMAD complex binds CDKN1A gene promoter [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by The complex of phosphorylated SMAD2/3 and SMAD4, bound to FO... (9618007)